Amano, Akiko
Sanjo, Nobuo
Araki, Wataru
Anraku, Yasutaka
Nakakido, Makoto
Matsubara, Etsuro
Tomiyama, Takami
Nagata, Tetsuya
Tsumoto, Kouhei
Kataoka, Kazunori
Yokota, Takanori
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI grant 19K07836, KAKENHI grant 20K07798)
Japan Agency for Medical Research and Development (18dm0107063h0003, JP19dm0107063h0004, JP20dm0107063h0005)
Article History
Received: 13 June 2022
Accepted: 7 January 2023
First Online: 31 January 2023
Declarations
:
: All animal experiments were approved by the Guidelines for the Care and Use of Laboratory Animals, as stated by the iCONM (Innovation Center of NanoMedicine, Kawasaki, Japan) [Approval Number: G15-009-6]. All biochemical experiments were approved by the Research Safety Control Office for Gene Recombinant Organisms of Tokyo Medical and Dental University (TMDU) [Approval Number: G2018-012C7]. As client-owned animals were not used in this study, consent to participate was not required.
: Not applicable.
: The authors declare that they have no competing interests.